Search results
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 4.4% on Analyst Upgrade
ETF DAILY NEWS· 5 days agoNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) shares were up 4.4% on Tuesday after HC Wainwright raised their price target on the stock from $19.00 to $26.00. HC ...
uniQure director sells over $11k in company shares By Investing.com
Investing.com· 6 days agoIt is important to note that this was not a discretionary trade by Mr. Kaye. Following the...
Gilead surges as HIV prevention therapy shows 100% efficacy in late-stage trial By Proactive...
Investing.com· 3 days agoGilead Sciences Inc (NASDAQ:GILD, ETR:GIS) shares added more than 8% after the pharmaceutical firm...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 4 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Up After Analyst Upgrade
ETF DAILY NEWS· 5 days agoMirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) gapped up prior to trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $31.00 ...
89bio, Inc. (NASDAQ:ETNB) Receives $28.14 Consensus Price Target from Analysts
ETF DAILY NEWS· 6 days agoTwo equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price ...
The Best LED Face Masks To Improve Wrinkles And Acne, According To Dermatologists
Women's Health via AOL· 3 days agoThe best FDA-approved LED light therapy face masks, per dermatologists and editors, have benefits...
New Guidance on CGRPs: How/Will it Shape Clinical Practice?
Medscape· 4 days ago/Will it Change Clinical Practice? A position statement released by the American Headache Society...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoFind insight on Zealand Pharma’s petrelintide shot , Sarepta Therapeutics, EssilorLuxottica, and more in the latest Market Talks covering the Health Care...
Piper Sandler keeps 'Overweight' on Allogene stock, highlights CAR-T potential By Investing.com
Investing.com· 6 days agoOn Monday, Piper Sandler reaffirmed its Overweight rating on Allogene Therapeutics (NASDAQ:ALLO)...